InflaRx N.V. (IFRX)
NASDAQ·Healthcare·Biotechnology
$1.65
+2.48%
Mkt Cap $64.44M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$2.00
Range $2.00 – $2.00
Implied Upside
+21.6%
Consensus $2.00 vs current $1.65
NASDAQ·Healthcare·Biotechnology
$1.65
+2.48%
Mkt Cap $64.44M
No recent rating data.
Price Target (3 analysts)
$2.00
Range $2.00 – $2.00
+21.6%
Consensus $2.00 vs current $1.65